Imagen de Portada

Incertus.jl -- The Julia Lego Blocks for Randomized Clinical Trial Designs

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Ryeznik, Yevgen, Sverdlov, Oleksandr
Formato:	Preprint
Publicado:	2024
Materias:	Methodology Computation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
por: Sverdlov, Oleksandr, et al.
Publicado: (2025)

Estimands for Randomized Discontinuation Designs in Oncology
por: Mukherjee, Ayon, et al.
Publicado: (2025)

Randomization Restrictions: Their Impact on Type I Error When Experimenting with Finite Populations
por: Chipman, Jonathan J., et al.
Publicado: (2025)

Randomization-based Inference for MCP-Mod
por: Pin, Lukas, et al.
Publicado: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
por: Johannes Krisam, et al.
Publicado: (2024)

SequentialSamplingModels.jl: Simulating and Evaluating Cognitive Models of Response Times in Julia
por: Fernandez, Kianté, et al.
Publicado: (2024)

bamlss: A Lego Toolbox for Flexible Bayesian Regression (and Beyond)
por: Umlauf, Nikolaus, et al.
Publicado: (2019)

Adjusted Random Effect Block Bootstraps for Highly Unbalanced Clustered Data
por: Tho, Zhi Yang, et al.
Publicado: (2025)

A Connection Between Covariate Adjustment and Stratified Randomization in Randomized Clinical Trials
por: Zhang, Zhiwei
Publicado: (2024)

A General Form of Covariate Adjustment in Randomized Clinical Trials
por: Bannick, Marlena S., et al.
Publicado: (2023)

Design of Bayesian Clinical Trials with Clustered Data
por: Hagar, Luke, et al.
Publicado: (2025)

The Win Ratio at the Design Stage of Clinical Trials
por: Kronthaler, David, et al.
Publicado: (2025)

Improve Sensitivity Analysis Synthesizing Randomized Clinical Trials With Limited Overlap
por: Jiang, Kuan, et al.
Publicado: (2024)

Clarifying the Role of the Mantel-Haenszel Risk Difference Estimator in Randomized Clinical Trials
por: Qiu, Xiaoyu, et al.
Publicado: (2024)

Prediction Intervals for Interim Events in Randomized Clinical Trials with Time-to-Event Endpoints
por: Ratti, Edoardo, et al.
Publicado: (2026)

A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
por: Zhang, Zhiwei, et al.
Publicado: (2025)

The RobinCar Family: R Tools for Robust Covariate Adjustment in Randomized Clinical Trials
por: Bannick, Marlena, et al.
Publicado: (2026)

Using Recursive Partitioning to Find and Estimate Heterogenous Treatment Effects In Randomized Clinical Trials
por: Berk, Richard A., et al.
Publicado: (2018)

Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials
por: Ren, Boyu, et al.
Publicado: (2025)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
por: Phillips, Rachael V., et al.
Publicado: (2024)

ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
por: Wang, Shuqi, et al.
Publicado: (2024)

The Optimality of Blocking Designs in Equally and Unequally Allocated Randomized Experiments with General Response
por: Azriel, David, et al.
Publicado: (2022)

TrialEmulation: An R Package to Emulate Target Trials for Causal Analysis of Observational Time-to-event Data
por: Su, Li, et al.
Publicado: (2024)

Random Indicator Imputation for Missing Not At Random Data
por: Jolani, Shahab, et al.
Publicado: (2024)

TWIN-GPT: Digital Twins for Clinical Trials via Large Language Model
por: Wang, Yue, et al.
Publicado: (2024)

Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
por: Hua, Kaiyuan, et al.
Publicado: (2024)

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data
por: Qiu, Sky, et al.
Publicado: (2025)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
por: DAngelo, Gina, et al.
Publicado: (2025)

Design-based Causal Inference for Incomplete Block Designs
por: Koo, Taehyeon, et al.
Publicado: (2024)

A Bayesian Nonparametric Stochastic Block Model for Directed Acyclic Graphs
por: Lee, Clement, et al.
Publicado: (2023)

Causal Inference in Randomized Trials with Partial Clustering
por: Nugent, Joshua, et al.
Publicado: (2024)

Some Bayesian Perspectives on Clinical Trials
por: Sokolova, Alexandra, et al.
Publicado: (2026)

A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
por: Zhan, Tianyu
Publicado: (2023)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)

Robust Covariate Adjustment in Multi-Center Randomized Trials
por: Alene, Muluneh, et al.
Publicado: (2025)

Omitted-Variable Sensitivity Analysis for Generalizing Randomized Trials
por: Asiaee, Amir, et al.
Publicado: (2026)

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials
por: Wang, Hao, et al.
Publicado: (2025)

Evaluating Informative Cluster Size in Cluster Randomized Trials
por: Blette, Bryan S., et al.
Publicado: (2025)

A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
por: Sun, Hao, et al.
Publicado: (2025)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
por: Pramanik, Paramahansa, et al.
Publicado: (2026)